Complete genome sequences of nine double recombinant vaccine-derived novel oral poliovirus type 2 genomes from Nigeria 2023-2024.

Autor: Castro CJ; Tanaq Management Services, LLC, contracting company for the Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Oderinde BS; World Health Organization National Polio Laboratory, University of Maiduguri Teaching Hospital, Maiduguri, Borno State, Nigeria., Poston KD; Tanaq Management Services, LLC, contracting company for the Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Mawashi KY; World Health Organization National Polio Laboratory, University of Maiduguri Teaching Hospital, Maiduguri, Borno State, Nigeria., Bullard K; Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Akinola M; World Health Organization National Polio Laboratory, University of Maiduguri Teaching Hospital, Maiduguri, Borno State, Nigeria., Meade C; Tanaq Management Services, LLC, contracting company for the Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Liu H; Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Hu F; Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Bullows JE; Tanaq Management Services, LLC, contracting company for the Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Gonzalez Z; Tanaq Management Services, LLC, contracting company for the Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Pang H; Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Sarris S; Tanaq Management Services, LLC, contracting company for the Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Agha C; Tanaq Management Services, LLC, contracting company for the Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Dybdahl-Sissoko N; Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Perry DB; Tanaq Management Services, LLC, contracting company for the Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., McDuffie L; Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Henderson E; Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Burns CC; Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Jorba J; Polio and Picornavirus Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Baba M; World Health Organization National Polio Laboratory, University of Maiduguri Teaching Hospital, Maiduguri, Borno State, Nigeria.

Publikováno v: Microbiology resource announcements [Microbiol Resour Announc] 2024 Oct 29, pp. e0088124. Date of Electronic Publication: 2024 Oct 29.

Experience and findings from surveillance peer review in Nigeria, August 2017-May 2019.

Autor: Hamisu AW; World Health Organization, Nigeria Country Office, Abuja, Nigeria., Etapelong SG; World Health Organization, Nigeria Country Office, Abuja, Nigeria., Ayodeji I; World Health Organization, Nigeria Country Office, Abuja, Nigeria., Richard B; World Health Organization, Nigeria Country Office, Abuja, Nigeria., Fiona B; World Health Organization, Nigeria Country Office, Abuja, Nigeria., Gidado S; National Stop Transmission of Polio (NSTOP)/African Field Epidemiology Network (AFENET), Aso, Federal Capital Territory, Abuja, Nigeria., Abbott SL; National Stop Transmission of Polio (NSTOP)/African Field Epidemiology Network (AFENET), Aso, Federal Capital Territory, Abuja, Nigeria., Edukugho AA; National Stop Transmission of Polio (NSTOP)/African Field Epidemiology Network (AFENET), Aso, Federal Capital Territory, Abuja, Nigeria., Bolu O; Centers for Disease Control and Prevention, Atlanta, Georgia, United States., Adeyelu A; Centers for Disease Control and Prevention, Atlanta, Georgia, United States., Mawashi KY; National Primary Healthcare Development Authority, Abuja, Nigeria., Adamu US; National Primary Healthcare Development Authority, Abuja, Nigeria., Nsubuga P; Global Public Health Solutions, Atlanta, Georgia, United States., Shuaib F; National Primary Healthcare Development Authority, Abuja, Nigeria.

Publikováno v: The Pan African medical journal [Pan Afr Med J] 2023 Aug 24; Vol. 45 (Suppl 2), pp. 9. Date of Electronic Publication: 2023 Aug 24 (Print Publication: 2023).

Enhancing acute flaccid paralysis surveillance system towards polio eradication: reverse cold chain monitoring in Nigeria, 2017 to 2019.

Autor: Abbott SL; African Field Epidemiology Network, Abuja, Nigeria., Hamisu AW; World Health Organization, Abuja, Nigeria., Gidado S; African Field Epidemiology Network, Abuja, Nigeria., Etapelong SG; World Health Organization, Abuja, Nigeria., Edukugho AA; African Field Epidemiology Network, Abuja, Nigeria., Hassan IA; World Health Organization, Abuja, Nigeria., Mawashi KY; National Primary Health Care Development Agency, Abuja, Nigeria., Bukbuk DN; Polio Laboratory, University of Maiduguri, Borno State, Nigeria., Baba M; Polio Laboratory, University of Maiduguri, Borno State, Nigeria., Adekunle AJ; Polio Laboratory, University College Hospital Ibadan, Oyo State, Nigeria., Adamu US; National Primary Health Care Development Agency, Abuja, Nigeria., Damisa E; National Primary Health Care Development Agency, Abuja, Nigeria., Waziri NE; African Field Epidemiology Network, Abuja, Nigeria., Archer WR; Centre for Disease Control and Prevention, Atlanta, Georgia., Franka R; Centre for Disease Control and Prevention, Atlanta, Georgia., Wiesen E; Centre for Disease Control and Prevention, Atlanta, Georgia., Braka F; World Health Organization, Abuja, Nigeria., Bolu O; Centre for Disease Control and Prevention, Nigeria Office, Abuja, Nigeria., Banda R; World Health Organization, Abuja, Nigeria., Shuaib F; National Primary Health Care Development Agency, Abuja, Nigeria.

Publikováno v: The Pan African medical journal [Pan Afr Med J] 2021 Nov 12; Vol. 40 (Suppl 1), pp. 7. Date of Electronic Publication: 2021 Nov 12 (Print Publication: 2021).